A. J. Smit

1.8k total citations
41 papers, 1.3k citations indexed

About

A. J. Smit is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. J. Smit has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 7 papers in Nephrology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. J. Smit's work include Blood Pressure and Hypertension Studies (9 papers), Advanced Glycation End Products research (6 papers) and Dialysis and Renal Disease Management (5 papers). A. J. Smit is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Advanced Glycation End Products research (6 papers) and Dialysis and Renal Disease Management (5 papers). A. J. Smit collaborates with scholars based in Netherlands, Pakistan and United States. A. J. Smit's co-authors include Thera P. Links, W. H. Eisma, Eric van Sonderen, Johan W. Groothoff, J. W. G. Meijer, Klaas Hoogenberg, Rijk O. B. Gans, J. D. Lefrandt, W. D. Reitsma and Robert de Vries and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and European Heart Journal.

In The Last Decade

A. J. Smit

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. Smit Netherlands 18 394 365 294 249 222 41 1.3k
Barbara H. Waberski United States 10 253 0.6× 576 1.6× 494 1.7× 255 1.0× 337 1.5× 10 1.2k
A. Dejgaard Denmark 17 234 0.6× 804 2.2× 325 1.1× 329 1.3× 142 0.6× 46 1.6k
P. Liam Oey Netherlands 24 1.1k 2.8× 247 0.7× 261 0.9× 295 1.2× 376 1.7× 47 1.9k
H. J. G. Gundersen Denmark 19 281 0.7× 329 0.9× 204 0.7× 172 0.7× 44 0.2× 31 1.1k
Manja Reimann Germany 19 319 0.8× 261 0.7× 129 0.4× 128 0.5× 93 0.4× 45 1.2k
T. M. Greenaway Australia 18 140 0.4× 404 1.1× 324 1.1× 153 0.6× 133 0.6× 40 1.3k
Jingtao Dou China 20 266 0.7× 799 2.2× 163 0.6× 310 1.2× 54 0.2× 94 1.4k
Stephen Podolsky United States 19 442 1.1× 418 1.1× 233 0.8× 176 0.7× 147 0.7× 45 1.4k
Christian Stevns Hansen Denmark 17 422 1.1× 336 0.9× 203 0.7× 258 1.0× 75 0.3× 67 1.0k
Alfons J.H.M. Houben Netherlands 18 380 1.0× 310 0.8× 263 0.9× 95 0.4× 52 0.2× 26 1.2k

Countries citing papers authored by A. J. Smit

Since Specialization
Citations

This map shows the geographic impact of A. J. Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Smit more than expected).

Fields of papers citing papers by A. J. Smit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Smit. The network helps show where A. J. Smit may publish in the future.

Co-authorship network of co-authors of A. J. Smit

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Smit. A scholar is included among the top collaborators of A. J. Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Smit. A. J. Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smit, A. J., Gwyneth W. Y. Wu, Ryan Rampersaud, et al.. (2024). Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder. Psychoneuroendocrinology. 165. 107045–107045. 6 indexed citations
2.
Oeveren, Wim van, A. J. Smit, Bernd Stegmayr, et al.. (2015). The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients. European Journal of Clinical Nutrition. 69(3). 309–313. 9 indexed citations
3.
Smith, Ian, Peter Kranke, I. Murat, et al.. (2012). Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. 6(1). 41–59. 100 indexed citations
4.
Mulder, Douwe J., et al.. (2012). Skin autofluorescence and risk of micro‐ and macrovascular complications in patients with Type 2 diabetes mellitus—a multi‐centre study. Diabetic Medicine. 29(12). 1556–1561. 75 indexed citations
5.
Perruchoud, Christophe, et al.. (2010). Intrathecal administration of Ziconotide: does single-shot injection predict efficacy?. IRIS. 1 indexed citations
6.
Meerwaldt, Robbert, et al.. (2008). Clinical Relevance of Advanced Glycation Endproducts for Vascular Surgery. European Journal of Vascular and Endovascular Surgery. 36(2). 125–131. 14 indexed citations
7.
Leeuw, Karina de, Robert de Vries, Robin P. F. Dullaart, et al.. (2007). Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Lara D. Veeken. 46(10). 1551–1556. 55 indexed citations
8.
Meerwaldt, Robbert, Thera P. Links, Klaas Hoogenberg, et al.. (2005). Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia. 48(8). 1637–1644. 145 indexed citations
9.
Vries, Robert de, Geesje M. Dallinga‐Thie, A. J. Smit, et al.. (2005). Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia. 49(2). 398–404. 72 indexed citations
10.
Meijer, J. W. G., A. J. Smit, Eric van Sonderen, et al.. (2002). Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabetic Medicine. 19(11). 962–965. 239 indexed citations
11.
Links, Thera P., et al.. (2001). Redistribution of blood volume in Type I diabetes. Diabetologia. 44(4). 429–432. 9 indexed citations
12.
Reyners, A.K.L., et al.. (2000). Re-evaluation of the cold face test in humans. European Journal of Applied Physiology. 82(5-6). 487–492. 21 indexed citations
13.
Heesen, Wilfred F., et al.. (2000). Isolated Systolic Hypertension from a Vascular Point of View. Journal of Vascular Research. 37(6). 485–493. 7 indexed citations
14.
Lefrandt, J. D., et al.. (1999). Baroreflex sensitivity is depressed in microalbuminuric Type I diabetic patients at rest and during sympathetic manoeuvres. Diabetologia. 42(11). 1345–1349. 52 indexed citations
15.
Reitsma, W. D., et al.. (1997). Reproducibility of Vitreous Fluorophotometry in Patients with Type 1 Diabetes Mellitus. Ophthalmologica. 211(4). 209–213. 1 indexed citations
16.
Smit, A. J., et al.. (1996). Alteration of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation. European Heart Journal. 17(6). 926–934. 12 indexed citations
17.
Lieverse, Aloysius G., Armand R. J. Girbes, D.J. van Veldhuisen, et al.. (1995). The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure. European Heart Journal. 16(7). 937–942. 4 indexed citations
18.
Smit, A. J., S. Meijer, H. Wesseling, A. J. M. Donker, & W. D. Reitsma. (1991). The effects of alpha-adrenoceptor blockade on dopamine-induced renal vasodilation and natriuresis. Naunyn-Schmiedeberg s Archives of Pharmacology. 343(2). 143–148. 3 indexed citations
19.
Smit, A. J., et al.. (1990). Renal and Endocrine Effects of Fenoldopam and Metoclopramide in Normal Man. ˜The œNephron journals/Nephron journals. 56(2). 179–185. 33 indexed citations
20.
Smit, A. J.. (1990). Dopamine in Chronic Renal Failure. American Journal of Hypertension. 3(6_Pt_2). 75S–77S. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026